Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HDM1002

HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

Huadong Medicine · Phase 1 · Status n/r · Enrollment 72

NCT06520540

ArmPopulationDoseWeeksEstimandWeight change
HDM1002 100 mgGlucagon-Like Peptide-1 Receptor Agonists100 mg12n/rn/r
HDM1002 200 mgGlucagon-Like Peptide-1 Receptor Agonists200 mg12n/rn/r
HDM1002 400 mgGlucagon-Like Peptide-1 Receptor Agonists400 mg12n/rn/r
PlaceboGlucagon-Like Peptide-1 Receptor Agonistsn/r12n/rn/r